The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
Nature. 2012 Jun 14; 486(7402):266-70
Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, ..., Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA. Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM, Grimmond SM, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA. Nature. 2012 Jun 14; 486(7402):266-70
This study identifies the X-linked deubiquitinase USP9X as a new tumor suppressor gene for pancreatic cancer. Using the Sleeping Beauty transposon-mediated insertional mutagenesis system, the authors show that the loss of USPX9 accelerates KRAS-induced tumorigenesis and protects pancreatic cancer cells from anoikis. Further characterization...
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthSend a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.